Clinical trial
Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia
NCT00327054 · Aga Khan University, Other · Completed
Key facts
| NCT number | NCT00327054 |
|---|---|
| Title | Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia |
| Official title | Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia: A Randomized Controlled Trial |
| Lead sponsor | Aga Khan University, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia, Hypertension, Diabetes Mellitus, Metabolic Syndrome X |
| Intervention type | Drug |
| Interventions | Nigella sativa seed |
| Enrollment | 80 |
| Start date | Feb 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | May 17, 2006 |
| Last update posted | Jul 1, 2015 |
| Countries | Pakistan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: